DMRA Q3'26 Earnings Preview: Revenue Estimate Is 0 USD
DMRA is scheduled to report Q3'26 results on October 30; the report time is unspecified. Revenue is estimated at 0 USD and EPS at (0.48) USD.
Damora Therapeutics, Inc. is scheduled to report Q3'26 results on October 30; the announcement time is not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC). For Q3'26, revenue is estimated at 0 USD, while EPS (earnings per share) is forecast at (0.48) USD.